Browse diseases

…This analysis of all ROP screening and treatment episodes from 2019 (one year prior to t…

…demonstrated efficacy and short-term safety in the treatment of retinopathy of prematurity (ROP), establishing them as the preferred option for zone I and…

… in group 3, 23% in group 4, 20% in group 5 and 68% in group 6. Nystagmus was observed in 0.8%, 0.4%, 1.8%, 2.6%, 5.0% and 47% in the res…

…Objectives Retinopathy of prematurity (ROP) is a leading cause of blindness in children worldwide, re…

… noted in 5.4%. The mean corrected gestational age at Threshold ROP diagnosis was 36 weeks.All ROP cases received treatment: 78% wi…

…Introduction Retinopathy of prematurity (ROP) is a significant cause of blindness and visual impairment in pr…

…ditional predictor, to identify infants requiring treatment for retinopathy of prematurity (ROP) in a contemporary Swedish cohort, estimate potential cost savin…

…o neonatal intensive care unit (NICU) health workers know about retinopathy of prematurity (ROP)? A qualitative study at a Regional Referral Hospital in U…

…l age. This study analyses screening and treatment pathways for retinopathy of prematurity (ROP) in these infants, assessing costs and health outcomes to develo…

…intravitreal injection (IVI) on the optic nerve in infants with retinopathy of prematurity (ROP) during long-term follow-up.Methods The preterm infants included…

…rtality rate. Secondary outcomes included comorbidities such as hypothermia, hypoglycaemia, acidosis, intraventricular haemorrhage (IVH), p…